

Insomnia was started in a college dorm room at the University of Pennsylvania and has expanded to over 100 stores nationwide, including one in San Marcos. Insomnia’s Austin retail hours are from 11 a.m. The menu will remain the same as other locations, with 12 flavors of cookies (think chocolate chunk, s’mores, peanut butter chip), which can be made into ice cream sandwiches, brownies, and cakes. Insomnia Cookies operates both a bakery and a delivery service, which will bring still-warm cookies to your door until 3 a.m. National chain Insomnia Cookies is moving into 2323 San Antonio Street by campus (as pointed out by an eagle-eyed tipster), and is now open as of Friday, November 8, while local bakery Kellie’s Baking Company (at 5245 Burnet Road) announced a delivery service as of late May. The study, “ Cognitive behavior therapy for insomnia in cancer patients: a systematic review and network meta-analysis” was published in the Journal of Evidence-Based Medicine.Austin is getting two new options to fulfill cookie cravings - including a bakery that delivers until 3 a.m. “The low quality of evidence and limited sample size demonstrate the need for robust evidence from high-quality, large-scale trials providing long-term follow-up data.” Group CBT-I is the preferred choice based on post intervention and short-term effects,” they concluded. “CBT-I is effective for the management of insomnia in cancer patients post intervention, with diminished effects in short-term follow-up. However, when compared with the inactive control, the CBT-I group demonstrated an increase in sleep efficiency (10.61%), total sleep time (21.98 minutes), a reduction of sleep onset latency (14.65 minutes), as well as a reduction in wake after sleep onset (24.30 minutes) at post intervention, with sustained effects during the short-term follow up. “Most of the results were rated as “moderate” to “low” certainty of evidence.” “These effects diminished in short-term follow-up and almost disappeared in long-term follow-up,” investigators reported. Insomnia severity was significantly impacted when compared to the active control, with wake after sleep onset being reduced post intervention as well. When evaluating the impact of the targeted intervention alongside the inactive control, CBT-I significantly reduced insomnia severity and increased sleep efficiency post intervention. Investigators identified 16 unique trials, including 1523 patients, that met inclusion criteria. Strongest Effects Observed Post Intervention Primary outcomes included insomnia severity, sleep efficiency, sleep onset latency (SOL), wake after sleep onset (WASO), and total sleep time (TST). The team reviewed 5 databases to gather data from randomized clinical trials that compared CBT-I with inactive or active controls for insomnia among patients with cancer. The multimodal intervention of CBT-I integrates various cognitive and behavioral treatment elements consisting of cognitive restructuring, sleep hygiene education, stimulus control strategies, sleep restriction, and relaxation training. Ya Gao, Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, and investigators performed a systematic review to examine which delivery format of cognitive behavioral therapy for insomnia (CBT-I) would be most effective in this patient population.Ĭognitive behavioral therapy has been shown to be effective at improving insomnia when implemented by reputable methods such as under the direction of a trained therapist, self-help automated programs, or delivered in individual, group, telephone, or computerized formats. Examining Insomnia Severity in Patients with Cancer

Additionally, insomnia brings with it a higher risk of cancer-related fatigue, depression, pain, memory problems, cardiovascular and mental disorders, immune function impairment, decreased quality of life, all-cause mortality, and cancer recurrence.

Therefore, these patients are 2-3 times more likely to experience disordered sleep as a consequence of the discomfort that accompanies their treatment. According to the study, 30%-60% of this population experiences insomnia, which is likely attributable to adverse events associated with cancer treatments like chemotherapy and radiotherapy. While insomnia is pervasive in the general population (10%-20%), it’s especially prevalent among oncology patients. However, investigators acknowledged that more high-quality, large-scale trials are needed to provide long-term follow-up data. New research indicated that cognitive behavioral therapy (CBT) is an effective management approach for insomnia experienced by patients with cancer.
